GLP-1 drug boom could create $22 billion market by 2035
J.P. Morgan says a GLP-1 boom in China, India and Brazil could create a $22 billion market by 2035. GLP-1 is a class of medicines used in weight and diabetes care.
पार्श्वभूमीGLP-1 drugs were first developed to help control blood sugar in diabetes and later became popular for weight loss. Their rising use in fast-growing markets is drawing attention from drugmakers, as many people in these countries have diabetes or obesity.
Reuters वर वाचा (इंग्रजी)
बर्निंग पोटॅटो स्कोअर: 24%